Why Jatenergy Ltd (ASX:JAT) shares doubled in value today

The Jatenergy Ltd (ASX:JAT) share price was on fire on Tuesday and doubled in value. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best performers on the Australian share market on Tuesday was the Jatenergy Ltd (ASX: JAT) share price.

The infant formula company's shares were up as much as 100% at one stage before closing the day 81.5% higher at 6.9 cents.

Why did Jatenergy's shares double in value today?

This afternoon Jatenergy released its quarterly update and revealed a significant increase in cash receipts.

According to the release, the company saw its cash receipts from sales increase from $320,000 in the June quarter to $10.7 million in the September quarter.

This was notably higher than the $8.7 million estimate that management had provided in August. Management has put this down to synergies between recent acquisitions starting to prove themselves.

Jatenergy did, however, report a net operating outflow for the quarter of $5.5 million. This was due to product manufacturing and operating costs of $15.4 million during the quarter compared to just $446,000 in the prior quarter.

The cash outflow is expected to rise to $16.8 million in the next quarter. Jatenergy finished the quarter with a cash balance of $1.6 million.

Should you buy Jatenergy shares?

As there is no mention of these cash flow figures being audited, I'm going to presume that they are unaudited. In light of this, I would suggest that investors take these sales figures with a pinch of salt.

Furthermore, with its cash balance at such low levels, I suspect a capital raising will be needed in the near future to fund its operations. This could act as a major drag on its share price if it is able to raise funds.

Overall, I think investors should continue to avoid Jatenergy's shares and focus on the shares of fellow infant formula companies A2 Milk Company Ltd (ASX: A2M) and Bellamy's Australia Ltd (ASX: BAL) instead.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

Why Develop Global, Empire Energy, Mineral Resources, and Pilbara Minerals shares are rising

These shares are ending the week strongly. But why?

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX biotech shares rocketing more than 40% on big news

These two ASX healthcare companies have exciting news for investors today.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Aurora Labs, Coronado Global, Latin Resources, and Newmont shares are rising

These shares are having a better day than most. But why?

Read more »

A woman is excited as she reads the latest rumour on her phone.
Share Gainers

Why Catalyst Metals, Ora Banda, Spartan Resources, and TechnologyOne shares are rising today

These shares are overcoming the market weakness and pushing higher. But why?

Read more »

Lab worker puts hands in the air and dances around
Healthcare Shares

Guess which ASX healthcare stock just rocketed 46% on major news!

Investors are sending this ASX healthcare stock flying higher on Wednesday. But why?

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why Arafura, Dropsuite, Spartan Resources, and Universal Store shares are pushing higher

These shares are having a strong session on Tuesday. But why?

Read more »

Man on a laptop thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield-eque start to the trading week this Monday.

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Healthcare Shares

If you invested $5,000 in this ASX pharmaceuticals stock a year ago, you'd have $34,711 now!

Just how lucky have investors been with this stock?

Read more »